A multicenter, double-blind, randomized, placebo-controlled study of MK0431 in patients with type 2 diabetes mellitus who have inadequate glycemic control.
Phase of Trial: Phase III
Latest Information Update: 20 Jun 2015
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme
- 31 Aug 2018 Biomarkers information updated
- 01 Feb 2014 Results published in the Drugs and Aging.
- 29 Jan 2009 Actual patient numbers changed from 500 to 530 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History